Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer
Satoshi Yoda
, Kenzo Soejima
, Junko Hamamoto
, Hiroyuki Yasuda
, Sohei Nakayama
, Ryosuke Satomi
, Hideki Terai
, Shinnosuke Ikemura
, Takashi Sato
, Katsuhiko Naoki
, Tomoko Betsuyaku
Research output
:
Contribution to journal
›
Article
›
peer-review
42
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Claudin-1
100%
MiR-375
100%
Overexpression
25%
Human Lung Cancer Cell Line
15%
Knockdown
10%
Squamous Cell Carcinoma (SqCC)
10%
Luciferase Reporter Assay
10%
Lung Adenocarcinoma
5%
High-level Expression
5%
Metastasis
5%
Protein Expression
5%
Clinical Significance
5%
Gene Expression Level
5%
3′-untranslated Region (3′-UTR)
5%
Luciferase Activity
5%
Survival Time
5%
Cell Migration
5%
Adenocarcinoma
5%
Direct Interaction
5%
Low Expression
5%
Target Gene Expression
5%
Differential Gene Expression
5%
Messenger RNA Expression
5%
Clinical Samples
5%
Wound Healing Assay
5%
SK-MES-1 Cells
5%
Biochemistry, Genetics and Molecular Biology
Claudin
100%
Cancer Cell
60%
Luciferase
60%
Cell Migration
20%
Precursor
20%
Protein Expression
20%
Survival Time
20%
Gene Expression Level
20%
Untranslated Region
20%
Differential Gene Expression
20%
Wound Healing Assay
20%
Messenger RNA
20%
Immunology and Microbiology
Claudin
100%
Lung Cancer Cell Line
60%
Squamous Cell
40%
Protein Expression
20%
Precursor
20%
Cell Migration
20%
Untranslated Region
20%
Survival Time
20%
Gene Expression Level
20%
Wound Healing Assay
20%
Differential Gene Expression
20%
Ribonucleic Acid
20%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Claudin 1
100%
microRNA 375
100%
Luciferase
15%
Adenocarcinoma
10%
Squamous Cell Carcinoma
10%
Survival Time
5%
Wound Healing
5%
Messenger RNA
5%